Integrating Cardiovascular Risk Assessment into Metabolic Dysfunction–associated Steatotic Liver Disease Drug Development. // Journal of Clinical and Experimental Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S0973688326002057?dgcid=rss_sd_all
Integrating Cardiovascular Risk Assessment into Metabolic Dysfunction–associated Steatotic Liver Disease Drug Development. Journal of Clinical and Experimental Hepatology. https://www.sciencedirect.com/science/article/pii/S0973688326002057?dgcid=rss_sd_all
“Integrating Cardiovascular Risk Assessment into Metabolic Dysfunction–associated Steatotic Liver Disease Drug Development.” Journal of Clinical and Experimental Hepatology.
@article{article52366,
title = {Integrating Cardiovascular Risk Assessment into Metabolic Dysfunction–associated Steatotic Liver Disease Drug Development},
journal = {Journal of Clinical and Experimental Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S0973688326002057?dgcid=rss_sd_all}
}